Abstract
DSC screening for drug-excipient interactions of a polypharmaceutical capsule dosage form containing salicylamide, ascorbic acid, pyrilamine maleate, phenylephrine hydrochloride, lactose, colloidal silicon dioxide and sodium starch glycolate was performed.